Women & Sex/Gender Differences Research Group

What We Do:

The mission of the Women and Gender Research Group is to promote the conduct, translation, and dissemination of drug abuse research on gender differences and issues specific to women.

Members:

• Cora Lee Wetherington, Ph.D., Chair
• Samia Dawud Noursi, Ph.D., Co-Chair

Center for the Clinical Trials Network (CCTN)

• Petra Jacobs, M.D. - (301) 496-8974 - clinical research and substance abuse treatment
• Carmen L. Rosa, M.S. - (301) 443-9830 - clinical research/clinical trials; regulatory affairs; health disparities/ethnic populations; women's health; and criminal justice
• Betty Tai, M.D. - (301) 443-6697 - clinical pharmacology; clinical trials relevant to clinical practice

Division of Basic Neuroscience & Behavioral Research (DBNBR)

• Beth Babecki, M.A. - (301) 435-0899 - training and career development
• Jerry Frankenheim, Ph.D. - (301) 435-1312 - neuroplasticity and neurotoxicology; methamphetamine and MDMA; marijuana; hallucinogens
• Samia Noursi, Ph.D. - (301) 594-5622 - sex/gender differences; women's health; children's social and emotional development; child maltreatment; domestic violence
• Vishnudutt Purohit, DVM, Ph.D. - (301) 594-5753 - prenatal and perinatal exposure of drugs; HIV/AIDS and HCV basic research; cardiovascular and hepatotoxicity; oxidative stress, inflammation, and apoptosis; epithelial and endothelial barriers, including blood brain barrier
• Joni Rutter, Ph.D. - (301) 443-1887 - genetics
• Cora Lee Wetherington, Ph.D. - (301) 435-1319 - basic behavioral laboratory research (animals and humans); prenatal drug exposure; sex/gender differences; vulnerability

Division of Clinical Neuroscience and Behavioral Research (DCNBR)

• Jessica Campbell Chambers, Ph.D. - (301) 443-2237 - adolescent and family behavioral treatment
• Joe Frascella, Ph.D. - (301) 443-4877 - clinical neurobiology; human neuroscience
• Debbie Grossman, M.A. - (301) 443-0107 - smoking cessation treatment for adults and adolescent; marijuana dependence treatment for adults; treatment for cognitively impaired drug users
• Mary Kautz, Ph.D., - 301-443-3206 - Neuropsychopharmacology, Human Behavioral Psychopharmacology, Smoking
• Lisa Onken, Ph.D. - (301) 443-2235 - combined behavioral and pharmacological TX; stages of behavioral treatment (TX) research; treatment of co morbid psychiatric disorders and drug abuse; mechanism of action of behavioral treatment
• Cece McNamara Spitznas, Ph.D. - (301) 402-1488 - treatment for stimulant & opioid abuse; integrating technology with treatment; therapist training and clinical supervision; behavioral, interpersonal, and psychotherapeutic approaches to change; HIV risk reduction

Division of Epidemiology, Services and Prevention Research (DESPR)

• Redonna K. Chandler, Ph.D. - (301) 443-6504 - criminal justice; gender differences; co-occurring disorders
• Dionne J. Jones, Ph.D. - (301) 402-1984 - interventions and treatment services for HIV/AIDS; gender differences; co-occurring disorders; ethnic populations (african american)
• Elizabeth Lambert, M.Sc. - (301) 402-1933 - natural history and epidemiology of HIV/AIDS among drug users; HIV/AIDS and drug abuse; clinical epidemiology and HIV disease
• Jacqueline Lloyd, Ph.D. - (301) 443-8892 - drug abuse prevention interventions; HIV prevention in at risk populations; peer and social network prevention interventions; role of family and peer factors on adolescent drug use
• Marsha Lopez, Ph.D. - (301) 443-6504 - epidemiology of drug use and disorder; comorbidity of drug and other psychiatric disorders; national studies examining the patterns of drug use and disorder across the life course; research training

Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)

• Kris Bough, Ph.D., 301-443-9800 - smoking cessation treatment, clinical drug development, neuroscience
• Jag H. Khalsa, Ph.D. - (301) 443-2159 - medical consequences of drugs of abuse and co-occurring infections including HIV, Hepatitis C, STDs, TB and others
• Amrat P. Patel, Ph.D. - (301) 443-8476 - molecular pharmacology; medications development; pharmacokinetics

Office of Extramural Affairs (OEA)

• Teri Levitin, Ph.D. - (301) 443-2755 - NIH and NIDA extramural policies and procedure; including grant review

Office of Science Policy and Communications (OSPC)

• Ericka M. Boone, Ph.D. - (301) 443-6036 - social neuroscience; psychopharmacology; basic behavioral laboratory research; research training
• Elizabeth Davis, M.P.H. - (301) 594-6317 - adolescent behavior; community-based research; public health
• Jennifer Elcano, M.A. - (301) 594-6314 - science writing; prescription drugs; gender differences; pharmacotherapies
• Carol Krause, M.A. - (301) 594-6148 - public education and outreach; media; web content; social marketing
• Susan Weiss, Ph.D. - (301) 443-6071 - science policy and research; training

Office of the Director

• Ana Anders - (301) 443-0441 - ethnic populations populations (hispanic-latino and asian american and pacific islander)
• Katherine Davenny, M.P.H. - (301) 443-2146 - HIV/AIDS & other infectious diseases; medical consequences; medical/prevention interventions; mother-infant transmission; cross-NIH collaborations
• Lynda Erinoff, Ph.D. - (301) 402-1972 - pharmacology; neuroscience; AIDS
• Denise Pintello, Ph.D., M.S.W. - (301) 594-6316 - gender differences; sexual abuse and trauma; child maltreatment; child and adolescent development
• Dale Weiss - (301) 443-6036 - international research collaboration; international research training; international research funding

Contact:

Any questions or concerns regarding the Women and Gender Research Group please contact Cora Lee Wetherington, Ph.D. (301) 435-1319 or wetherington@nih.gov and/or Samia Dawud Noursi, Ph.D. (301) 594-5622.